Medilente Pharma Private Limited

Tofacitinib tablets 5mg IP are used to treat moderate to severe rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis in adults. Tofacitinib is classified as a Janus kinase (JAK) inhibitor, which works by blocking specific enzymes involved in the inflammatory processes of these autoimmune diseases. By inhibiting these enzymes, Tofacitinib helps reduce inflammation, pain, and joint damage, improving the overall quality of life for patients with these conditions.

Key Ingredient: 

• Tofacitinib 5mg: A Janus kinase (JAK) inhibitor that helps reduce inflammation and modulate the immune response in autoimmune diseases.

Indications: 

• Treatment of moderate to severe rheumatoid arthritis in patients who have not responded adequately to other treatments

• Management of psoriatic arthritis

• Treatment of ulcerative colitis, an inflammatory bowel disease

Benefits: 

• Reduces Inflammation: Helps manage symptoms of autoimmune diseases by targeting and inhibiting JAK enzymes, leading to reduced inflammation and joint damage.

• Improves Joint Function: Slows the progression of joint damage, helping improve mobility and daily activities for those with RA and psoriatic arthritis.

• Flexible Treatment: Offers an alternative to biologic therapies, providing another option for patients who do not respond to traditional treatments.

Usage Instructions: 

Tofacitinib tablets are taken orally as prescribed by a healthcare provider. The usual dosage is 5mg, and the number of doses per day depends on the condition being treated. It’s important to follow the prescribed regimen closely and have regular check-ups to monitor the treatment’s effectiveness.

Side Effects: 

Common side effects include headaches, high blood pressure, and infections such as the common cold. Serious side effects may include liver problems, blood clots, and serious infections. Consult your doctor if you experience any unusual symptoms.

Tofacitinib 5mg tablets provide an effective solution for managing autoimmune diseases, particularly for patients who have not responded well to other treatments, helping improve symptoms and prevent further disease progression.

Additional Information:

• Production Capacity: 5000